Hung N Luu

MD, PhD
  • Assistant Professor
  • Faculty in Epidemiology

Dr. Luu has a broad background in medicine and epidemiology, with specific training and expertise in the molecular and genetic epidemiology of cancer as well as large population-based studies. His main research focuses on etiological role of genetic factors, lifestyle factors, and environment exposures, particularly chronic inflammation, in the development of cancer as well as their impact on prognosis of cancer patients. His current cancer outcomes include GI tract cancers (i.e., colorectal cancer, pancreatic cancer and liver cancer). Other research interests include biomarkers identification for diagnostic and prognostic of cancer; host-virus/bacteria interaction in carcinogenesis; and gene-environmental and gene-gene interaction in cancer. Dr. Luu has extensive experience working with large prospective cohort studies such as the Southern Community Cohort Study-SCCS, the Shanghai Men’s Health Study-SMHS, and the Shanghai Women’s Health Study-SWHS. At the University of Pittsburgh, Dr. Luu has actively involved into two large prospective cohort studies: 1) the Shanghai Chinese Health Study (SCHS) and 2) the Shanghai Cohort Study (SCS). He is also an active member of several cancer consortium such as the Asia Cohort Consortium (ACC), the Stomach cancer Pooling Project-SToP Consortium and a founding member of the International Liver Cancer Epidemiology Consortium (ILCEC).

Education

2015 | Vanderbilt University | Post-doctoral Fellow

2013 | Baylor College of Medicine | Post-doctoral Associate

2011 | University of Texas Health Science Center-Houston | PhD, Epidemiology

2003 | Tulane University | MPH, International Health/Health Economics

1997 | Thai Binh Medical University | MD, Medicine

Teaching

EPI2171: Cancer Epidemiology

Selected Publications
  1. Luu HN*, Neelakantan N, Wang R, Behari J, Adams-Haduch J, Goh GBB, Jin A, van Dam RM, Koh WP, Yuan JM. Quality diet indexes and risk of hepatocellular carcinoma: Findings from the Singapore Chinese Health Study.Int J Cancer 2021;148(9): 2102-2114. (PMID: 33129230) (*Corresponding author).
  2. Luu HN*, Wang R, Behari J, Adams-Haduch J, Odegaard AO, Goh GBB, Jin A, Koh WP, Yuan JM. Composite score of healthy lifestyle factors and risk of hepatocellular carcinoma: Findings from a prospective study.Cancer Epidemiol Biomarkers Prev 2021;30(2):380-387. (PMID: 33187965-PMCID: PMC7867589) (*Corresponding author).

  3. Luu HN*, Paragomi P, Wang R, Jin A, Brand RE, Koh WP, Yuan JM. Quality diet indexes and risk of pancreatic cancer: Findings from a prospective cohort study.Cancer Epidemiol Biomarkers Prev 2021;30(11):2068-2078 (PMID: 34446471; PMCID: PMC8568638) (*Corresponding author). (Trainee co-author)

  4. Luu HN*, Paragomi R, Wang R, Huang JY, �ivind M, Ulvik A, Nguyen TC, Brand RE, Gao Y-T, Uelan PM, Yuan JM. Association between serum serine and glycine and related-metabolites with pancreatic cancer in a prospective cohort study.Cancers. 2022;14(9):2199. (PMID: 35565328; PMCID: PMC9105477) (Trainee co-author;*Corresponding author).
  5. Luu HN*, Wang R, Paragomi P, Jin A, Brand RE, Koh WP, Yuan JM. Association between composite score of healthy lifestyle factors and the risk of pancreatic cancer: Findings from a prospective cohort study.Cancer Prev Res. 2022;15(1):29-36 (PMID: 34642175-PMCID: PMC8741646) (*Corresponding author) (Trainee co-author).
  6. Luu HN*, Tran MT, Nguyen MVT, Tran QH, Le LC, Pham HTT, Ha HTT, Shrubsole MJ, Cai Q, Ye F, Long J, Zheng W, Boffetta P, Shu XO, Tran CTD*. Association between body mass index and colorectal advanced adenomas: Findings form a case-control study in Vietnam. Int J Cancer 2021;149(11):1898-1909. (PMID: 34346504) (*Corresponding authors).
  7. Tran CTD, Nguyen, MVT, Tran MT, Tuong TVT, Tran QH, Le LC, Pham HTT, Bui NC, Vu HH, Nguyen TTC, Ta PQ, Ha HTT, Trinh DT, Le LH, Vu KV, Tran TV, Tran HTT, Shrubsole MJ, Long J, Ye F, Cai Q, Zheng W, Boffetta P*, Shu XO*,Luu HN*. Findings from the first colorectal cancer screening among 103,542 individuals in Vietnam and systematic review of colorectal cancer screening programs in Asia-Pacific Region.Jpn J Clin Oncol. 2022; Apr 5;hyac043. doi: 10.1093/jjco/hyac043. Online ahead of print. (PMID: 35383373) (*Corresponding author).
  8. Yu Y-C, Paragomi P, Wang R, Jin A, Schoen RE, Sheng LT, An P, Koh WP, Yuan J-M,Luu HN*. Comprehensive dietary antioxidant index (CDAI) and the risk of colorectal cancer: findings from the Singapore Chinese Health Study.Int J. Cancer 2022;150(10):1599-1608 (Trainee co-author;*Corresponding author) (PMID: 35001362; PMCID: PMC8930521)
Department/Affiliation